Oxford Asset Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-80,262
| Closed | -$67K | – | 2279 |
|
|
2019
Q3 | $67K | Sell |
80,262
-47,340
| -37% | -$39.5K | ﹤0.01% | 1641 |
|
|
2019
Q2 | $110K | Buy |
127,602
+22,217
| +21% | +$19.2K | ﹤0.01% | 1603 |
|
|
2019
Q1 | $102K | Sell |
105,385
-246,495
| -70% | -$239K | ﹤0.01% | 1563 |
|
|
2018
Q4 | $258K | Sell |
351,880
-81,122
| -19% | -$59.5K | 0.01% | 1454 |
|
|
2018
Q3 | $928K | Buy |
433,002
+155,996
| +56% | +$334K | 0.02% | 1039 |
|
|
2018
Q2 | $1.45M | Buy |
277,006
+35,147
| +15% | +$184K | 0.03% | 850 |
|
|
2018
Q1 | $943K | Buy |
241,859
+58,558
| +32% | +$228K | 0.02% | 966 |
|
|
2017
Q4 | $490K | Buy |
183,301
+132,090
| +258% | +$353K | 0.01% | 1185 |
|
|
2017
Q3 | $164K | Buy |
+51,211
| New | +$164K | ﹤0.01% | 1444 |
|
|
2016
Q4 | – | Sell |
-4,944
| Closed | -$19K | – | 966 |
|
|
2016
Q3 | $19K | Sell |
4,944
-3,286
| -40% | -$12.6K | ﹤0.01% | 761 |
|
|
2016
Q2 | $28K | Buy |
+8,230
| New | +$28K | ﹤0.01% | 774 |
|
|
2015
Q4 | – | Sell |
-1,047
| Closed | -$15K | – | 1058 |
|
|
2015
Q3 | $15K | Sell |
1,047
-120,376
| -99% | -$1.72M | ﹤0.01% | 619 |
|
|
2015
Q2 | $2.37M | Buy |
121,423
+51,166
| +73% | +$998K | 0.06% | 324 |
|
|
2015
Q1 | $1.27M | Buy |
+70,257
| New | +$1.27M | 0.03% | 423 |
|
|
2014
Q3 | – | Sell |
-30,865
| Closed | -$871K | – | 867 |
|
|
2014
Q2 | $871K | Sell |
30,865
-112,057
| -78% | -$3.16M | 0.03% | 510 |
|
|
2014
Q1 | $4.86M | Sell |
142,922
-28,464
| -17% | -$968K | 0.14% | 228 |
|
|
2013
Q4 | $3.29M | Buy |
+171,386
| New | +$3.29M | 0.08% | 327 |
|
|
2013
Q3 | – | Sell |
-3,384
| Closed | -$36K | – | 1050 |
|
|
2013
Q2 | $36K | Buy |
+3,384
| New | +$36K | ﹤0.01% | 854 |
|